Market Segmentation, Major Trends, and Competitive Analysis of the G-Protein Coupled Receptors Market

The G-protein coupled receptors (GPCR) market is poised for substantial expansion in the coming years, driven by advances in drug discovery and research technologies. This sector is experiencing heightened attention due to its critical role in targeted therapies and innovative pharmaceutical development. Below, we explore the market's anticipated growth, key industry players, emerging trends, and the detailed segmentation shaping its future.

Forecasted Market Size and Growth Path of the G-Protein Coupled Receptors Market
The global market for G-protein coupled receptors is projected to reach $4.77 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.0%. Several factors contribute to this robust growth, including increased demand for precision drug targeting, the integration of artificial intelligence in drug discovery, expansion of biologics in drug pipelines, advances in receptor deorphanization research, and escalating investments in translational research. Key trends expected to influence market dynamics over the forecast period include the rising use of GPCRs as drug targets, growth in high-throughput screening methods, intensified focus on orphan receptor studies, development of cell-based assay technologies, and stronger collaborations between academic institutions and pharmaceutical companies.

Download a free report of the g-protein coupled receptors market report:
https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Principal Companies Driving the G-Protein Coupled Receptors Industry
The GPCR market features a range of leading players actively shaping the industry landscape. Prominent companies include Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, and Boehringer Ingelheim. Other significant contributors are Daiichi Sankyo Company Limited, Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Bio-Techne Corporation, Abcam PLC, Cara Therapeutics Inc., Sosei Heptares Ltd., Eurofins DiscoverX Corporation, Crinetics Pharmaceuticals Inc., Domain Therapeutics SA, Addex Pharmaceuticals Ltd., Structure Therapeutics, and Septerna.

Danaher Corporation's Strategic Acquisition to Enhance GPCR Portfolio
In December 2023, Danaher Corporation, a US-based firm, completed the acquisition of UK-based Abcam Plc for an undisclosed sum. This move is intended to broaden Danaher's offerings by integrating Abcam's specialized capabilities in G-protein coupled receptors. Abcam Plc is known for providing GPCR-related products and technologies, marking this acquisition as a significant step toward strengthening Danaher's position in the GPCR market.

View the full g-protein coupled receptors market report:
https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Emerging Trends Signaling Growth in the GPCR Market Worldwide
Companies involved in medical device testing, inspection, and certification are increasingly prioritizing advanced services such as third-party verification and validation to build trust among customers and regulators. These services involve an independent entity assessing whether a product or process meets established standards. For example, in October 2023, UL Solutions, a US-based provider of testing and certification, launched medical device testing services at its Rochester Hills, Michigan laboratory. This expansion supports Michigan's growing medical device industry by enhancing product safety, security, usability, and interoperability. The facility now offers comprehensive third-party verification, validation, auditing, cybersecurity testing, usability assessments, and compliance training tailored to manufacturers' needs. It also features a controlled environment with reduced volatile organic compounds (VOCs) to ensure testing precision and reliability.

Detailed Segmentation of the G-Protein Coupled Receptors Market
The GPCR market is categorized in this report by product, assay type, and application area:

1) Product Segments:
- Cell Lines
- Detection Kits
- Cell Culture Reagents
- Ligands

2) Assay Types:
- CAMP Functional Assays
- Calcium Functional Assays
- ?-Arrestin Functional Assays
- Radioligand Binding and GTP?S Functional Assays
- Internalization Assays
- Trafficking Assays

3) Application Areas:
- Cancer Research
- CNS Research
- Metabolic Research
- Cardiovascular Research
- Inflammation Research
- Respiratory Research
- Other Applications

Further breakdown includes:

- Cell Lines: GPCR-Expressing Cell Lines, Stable and Transient Cell Lines
- Detection Kits: ELISA Kits, High-Throughput Screening Kits, Reporter Gene Assays
- Cell Culture Reagents: Media and Supplements, Transfection Reagents, Growth Factors
- Ligands: Agonists, Antagonists, Inverse Agonists

This detailed segmentation provides a comprehensive outlook on the various elements driving the G-protein coupled receptors market forward.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.